Matches in Nanopublications for { ?s ?p "[Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI-mediated mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP50930.RAZnRp4gYsas1fPM2OkRdf3baxSwTIg7R0xY4z8VLa3ns130_assertion description "[Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI-mediated mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP50930.RAZnRp4gYsas1fPM2OkRdf3baxSwTIg7R0xY4z8VLa3ns130_provenance.
- NP198978.RAlg1o1lCh5_yXhT1HxVsNjp9rYMCEunQDWAhOGJlaKN4130_assertion description "[Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI-mediated mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP198978.RAlg1o1lCh5_yXhT1HxVsNjp9rYMCEunQDWAhOGJlaKN4130_provenance.
- assertion description "[Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI-mediated mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP323713.RARxCBN0OiCtMu-6UaA3HKSBdxuO_qnBgf2T2gdNui1H4130_assertion description "[Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI-mediated mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323713.RARxCBN0OiCtMu-6UaA3HKSBdxuO_qnBgf2T2gdNui1H4130_provenance.
- assertion description "[Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI-mediated mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP421399.RAU40bFeZep_PGY2Rj5fJodJjyFZQs1X-PrOcLJ7Oxvgg130_assertion description "[Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI-mediated mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP421399.RAU40bFeZep_PGY2Rj5fJodJjyFZQs1X-PrOcLJ7Oxvgg130_provenance.
- NP421400.RAST867VSwY7ABI-jJ7t_xdLBvemQ5Q4zRqVQ0Fytjx6g130_assertion description "[Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI-mediated mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP421400.RAST867VSwY7ABI-jJ7t_xdLBvemQ5Q4zRqVQ0Fytjx6g130_provenance.
- NP63236.RA7GZ1d4_TzlC6aLzzJexdXY6Wh1rqrMT95G0PdO355e4130_assertion description "[Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI-mediated mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP63236.RA7GZ1d4_TzlC6aLzzJexdXY6Wh1rqrMT95G0PdO355e4130_provenance.
- NP323708.RAG36-FAUfLuXhxcBQJ2UYM6p1WDVNkktLbZ0KQ6XBmog130_assertion description "[Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI-mediated mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323708.RAG36-FAUfLuXhxcBQJ2UYM6p1WDVNkktLbZ0KQ6XBmog130_provenance.
- NP82616.RAMKInjQGJkt6mt2NjG37-7t61-iDTcFXjjPyGcQgDuDg130_assertion description "[Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI-mediated mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP82616.RAMKInjQGJkt6mt2NjG37-7t61-iDTcFXjjPyGcQgDuDg130_provenance.